Joshua Smiley
Presidente presso ZAI LAB LIMITED
Patrimonio netto: 52 664 $ in data 30/04/2024
Profilo
Attualmente, Joshua L. Smiley è tesoriere, direttore e vicepresidente di CoLucid Pharmaceuticals, Inc. Il signor Smiley è anche nel consiglio della Butler University e della Eskenazi Health Foundation. Nella sua carriera passata è stato Chief Financial Officer & Senior Vice President presso Eli Lilly & Co. e Chief Financial Officer, Controller & SVP-Finance presso Lilly Research Laboratories (una filiale di Eli Lilly & Co.). Joshua L. Smiley si è laureato alla Harvard University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ZAI LAB LTD.
0.00% | 13/05/2024 | 31 684 ( 0.00% ) | 52 664 $ | 30/04/2024 |
Posizioni attive di Joshua Smiley
| Società | Posizione | Inizio |
|---|---|---|
| ZAI LAB LIMITED | Presidente | - |
| Butler University | Direttore/Membro del Consiglio | - |
| Eskenazi Health Foundation | Direttore/Membro del Consiglio | - |
Unseen Capital LLC
 Unseen Capital LLC Investment ManagersFinance Unseen Capital LLC (Unseen Capital) is a venture capital firm founded in 2020 by Warnell Kayode Owens. The firm is headquartered in New York. | Consulente / Consigliere | - |
Precedenti posizioni note di Joshua Smiley
| Società | Posizione | Fine |
|---|---|---|
| ELI LILLY AND COMPANY | Direttore Finanziario/CFO | 09/02/2021 |
| ELANCO ANIMAL HEALTH INCORPORATED | Direttore/Membro del Consiglio | 11/03/2019 |
Lilly Research Laboratories
 Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Direttore Finanziario/CFO | 01/01/2015 |
| COLUCID PHARMACEUTICALS INC | Direttore/Membro del Consiglio | - |
Gilead Connecticut, Inc.
 Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Gilead Connecticut, Inc. manufactures pharmaceuticals and biotechnology chemicals. The firm develops a pipeline of small molecule therapeutics for multiple oncology and immunology-based indications. It focuses on the development of novel kinase inhibitors for the treatment of cancer, autoimmune, and inflammatory diseases. The company was founded in 2000 and is headquartered in Foster City, CA. | Direttore/Membro del Consiglio | - |
Formazione di Joshua Smiley
| Harvard University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| ELANCO ANIMAL HEALTH INCORPORATED | Health Technology |
| ZAI LAB LIMITED | Health Technology |
| Aziende private | 5 |
|---|---|
Gilead Connecticut, Inc.
Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Gilead Connecticut, Inc. manufactures pharmaceuticals and biotechnology chemicals. The firm develops a pipeline of small molecule therapeutics for multiple oncology and immunology-based indications. It focuses on the development of novel kinase inhibitors for the treatment of cancer, autoimmune, and inflammatory diseases. The company was founded in 2000 and is headquartered in Foster City, CA. | Health Technology |
Lilly Research Laboratories
Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Commercial Services |
CoLucid Pharmaceuticals, Inc.
 CoLucid Pharmaceuticals, Inc. BiotechnologyHealth Technology CoLucid Pharmaceuticals, Inc. engaged in the development of therapeutics for neurological disorders. Its products included Lasmiditan, a neurally acting anti-migraine agent that is designed to delivered efficacy in migraine without the vasoconstrictor activity associated with previous generations of migraine therapies and a Conjugated Stigmines platform that has generated a series of preclinical candidates for the chronic pain, Alzheimer's disease and psychiatric disorders. The company was founded by James F. White and Arthur M. Pappas in 2005 and was headquartered in Cambridge, MA. | Health Technology |
| Eskenazi Health Foundation | |
Unseen Capital LLC
Unseen Capital LLC Investment ManagersFinance Unseen Capital LLC (Unseen Capital) is a venture capital firm founded in 2020 by Warnell Kayode Owens. The firm is headquartered in New York. | Finance |
- Borsa valori
- Insiders
- Joshua Smiley
